Related Articles
Dihydromyricetin protects against lipopolysaccharide‑induced cardiomyocyte injury through the toll‑like receptor‑4/nuclear factor‑κB pathway
Astragalin and dihydromyricetin as adjuncts to histidine‑tryptophan‑ketoglutarate cardioplegia enhances protection during cardioplegic arrest
Dihydromyricetin induces cell cycle arrest and apoptosis in melanoma SK-MEL-28 cells
Dihydromyricetin induces apoptosis and inhibits proliferation in hepatocellular carcinoma cells
Dihydromyricetin inhibits oxidative stress and apoptosis in oxygen and glucose deprivation/reoxygenation‑induced HT22 cells by activating the Nrf2/HO‑1 pathway